Evidence map›Paper›PMID 31890489›Full record

ArticleMedical mycology case reports2020

Multi-fungal sepsis and mucormycosis of the central nervous system in a patient treated with ibrutinib, a case report and review of the literature.

Martin Fehr, Gieri Cathomas, Anne Graber, Eva Makert, Elisabeth Gaus, Katia Boggian

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medical mycology case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. mBio · 2024
    Article
  3. Article
  4. Leukemia followed by mixed infection with mucormycosis and aspergillosis: A case report and literature review.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Ibrutinib-associated cutaneous mucormycosis due to anTherapeutic advances in infectious disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Martin FehrDepartment for Medical Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland.
Gieri CathomasInstitute of Pathology, Cantonal Hospital Basel-Land, Liestal, Switzerland.
Anne GraberInstitute of Pathology, Cantonal Hospital Basel-Land, Liestal, Switzerland.
Eva MakertInstitute of Pathology, Cantonal Hospital St. Gallen, Switzerland.
Elisabeth GausInstitute of Pathology, Cantonal Hospital St. Gallen, Switzerland.
Katia BoggianDepartment for Infectious Diseases, Cantonal Hospital St. Gallen, Switzerland.
Kantonsspital St. Gallen · CHTheological Seminary Bienenberg · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the case of a 71 years old patient with chronic lymphocytic leukemia (CLL), who developed a rapidly progressing multi-fungal infection including mucormycosis of the central nervous system (CNS) during treatment with ibrutinib. On autopsy mucorales species were demonstrated intravascularly by histomorphology of several organs and lymph nodes and were characterized as

Indexed as

AspergillosisCerebral infectionChronic lymphocytic leukemiaCLLIbrutinibMucormykosis

Identifiers

PMID31890489
PMCPMC6926283
OpenAlexW2992626531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.